High BMI and COPD Outcomes in Alpha-1 Antitrypsin Deficiency

<h3>Background</h3> Elevations in BMI impact morbidity in patients with COPD in general, but little is known about its impact in patients with COPD due to alpha-1 antitrypsin deficiency (AATD-COPD). <h3>Research Question</h3> What is the prevalence and clinical impact of high BMI in AATD-COPD? <h3>Study Design and Methods</h3> A total of 646 patients completed clinical and health-related quality of life (HRQoL) questionnaires for 2 years. Patients were grouped by baseline BMI categories (underweight, normal, overweight, obese, and morbidly obese) to compare symptoms, exacerbations, HRQoL, and 5- and 10-year survival. Relation between changes in BMI over time on HRQoL was assessed. <h3>Results</h3> The cohort's mean age ± SD (55 ± 9.2 years), sex distribution (50.1% male), and mean % FEV<sub>1</sub> ± SD (36.6% ± 17.0%) was similar across all BMI categories. One-third (31.6%) had normal BMI, 5.6% were underweight, and 62% had a high BMI (37.3% overweight, 16.1% obese, and 9.4% morbidly obese). Patients with a high BMI had significantly worse St. George's Respiratory questionnaire (SGRQ) and 36-Item Short Form Survey (SF-36) physical composite scores than patients with normal weight. Patients with morbid obesity had the highest odds of being in the worst SGRQ (OR, 3.8; 95% CI, 1.9-7.8) and SF-36 physical composite (OR, 4.2; 95% CI, 2.1-8.1) quartiles and experienced more emergency department visits and hospitalizations than patients with normal weight (<i>P</i> < .05). Patients who transitioned to a higher BMI category over time reported worsening of SGRQ and SF-36 physical composite scores (<i>P</i> < .05) and vice versa. Despite their higher morbidity, no difference in survival was observed between patients with high BMI and normal BMI after a mean follow-up of 9 years. <h3>Interpretation</h3> BMI above normal is prevalent in patients with AATD-COPD and is associated with greater comorbidity and poor HRQoL but does not impact survival. HRQoL is inversely affected by BMI changes over time.

Authors

Institutions

Publication Details

Journal
CHEST Pulmonary
Published
2024-10-19
DOI
https://doi.org/10.1016/j.chpulm.2024.100113
Primary Topic
Protease and Inhibitor Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High BMI and COPD Outcomes in Alpha-1 Antitrypsin Deficiency

Jorge Lascano, Robert A. Sandhaus, Michael Campos, Brian Garnet et al.
CHEST Pulmonary
Protease and Inhibitor Mechanisms
article

High BMI and COPD Outcomes in Alpha-1 Antitrypsin Deficiency

Jorge Lascano, Robert A. Sandhaus, Michael Campos, Brian Garnet, Leonard Riley
article en

Abstract

<h3>Background</h3> Elevations in BMI impact morbidity in patients with COPD in general, but little is known about its impact in patients with COPD due to alpha-1 antitrypsin deficiency (AATD-COPD). <h3>Research Question</h3> What is the prevalence and clinical impact of high BMI in AATD-COPD? <h3>Study Design and Methods</h3> A total of 646 patients completed clinical and health-related quality of life (HRQoL) questionnaires for 2 years. Patients were grouped by baseline BMI categories (underweight, normal, overweight, obese, and morbidly obese) to compare symptoms, exacerbations, HRQoL, and 5- and 10-year survival. Relation between changes in BMI over time on HRQoL was assessed. <h3>Results</h3> The cohort's mean age ± SD (55 ± 9.2 years), sex distribution (50.1% male), and mean % FEV<sub>1</sub> ± SD (36.6% ± 17.0%) was similar across all BMI categories. One-third (31.6%) had normal BMI, 5.6% were underweight, and 62% had a high BMI (37.3% overweight, 16.1% obese, and 9.4% morbidly obese). Patients with a high BMI had significantly worse St. George's Respiratory questionnaire (SGRQ) and 36-Item Short Form Survey (SF-36) physical composite scores than patients with normal weight. Patients with morbid obesity had the highest odds of being in the worst SGRQ (OR, 3.8; 95% CI, 1.9-7.8) and SF-36 physical composite (OR, 4.2; 95% CI, 2.1-8.1) quartiles and experienced more emergency department visits and hospitalizations than patients with normal weight (<i>P</i> < .05). Patients who transitioned to a higher BMI category over time reported worsening of SGRQ and SF-36 physical composite scores (<i>P</i> < .05) and vice versa. Despite their higher morbidity, no difference in survival was observed between patients with high BMI and normal BMI after a mean follow-up of 9 years. <h3>Interpretation</h3> BMI above normal is prevalent in patients with AATD-COPD and is associated with greater comorbidity and poor HRQoL but does not impact survival. HRQoL is inversely affected by BMI changes over time.

CHEST PulmonaryVol. 3(1)
University of Miami (US), Veterans Health Administration (US), National Jewish Health (US), University of Florida (US), AlphaNet (US), Kansas City VA Medical Center (US), University of Colorado Denver (US)
Zero hunger
Openalex Percentile: Top 73%
Protease and Inhibitor Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.